Editor-in-Chief, Healthcare & Life Sciences, at Questex @FierceBiotech @FierceHealth @FiercePharma @FierceMedtech
Chicago
Joined March 2014
- Tweets6.1K
- Following1.1K
- Followers2.7K
- Likes2.7K
Ayla Ellison retweeted
Thanks. This is a very good and touching podcast from @FiercePharma @FierceBiotech by @AylaEllison
fiercepharma.com/pharma/peop… about my colleague @mtosterholm
From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotech fiercebiotech.com/biotech/th…
Ayla Ellison retweeted
The Trump administration's support could launch psychedelics across the regulatory finish line or doom the field to perpetual questions of legitimacy. fiercebiotech.com/biotech/re…
With Darzalex leading the charge, Johnson & Johnson is projecting that its 2026 revenue will reach $100 billion fiercepharma.com/pharma/led-…
Ayla Ellison retweeted
🎧 In this special year-end episode of "The Top Line," Fierce reporters take stock of 2025 and look ahead to the trends and questions that will shape 2026. fiercepharma.com/pharma/year…
Big Pharma is piling into MASH: GSK, Roche and Novo are building GLP-1 + FGF21 combo stacks. Inside the $10B+ bets and the readouts to watch. fiercepharma.com/pharma/big-…
Ayla Ellison retweeted
Bristol Myers Squibb has agreed to pay $1.5 billion to buy Orbital Therapeutics for a pipeline led by a preclinical CD19 autoimmune program. fiercebiotech.com/biotech/bm…
Ayla Ellison retweeted
Boehringer's Jascayd is the first new drug to break into the idiopathic pulmonary fibrosis field in more than a decade. fiercepharma.com/pharma/boeh…
Ayla Ellison retweeted
The Fierce 50 of 2025 is here. This is our annual look at the people and organizations advancing what’s possible in healthcare and biopharma. fiercepharma.com/collection/…
Startup Clairity scored a green light from the FDA for the agency's first artificial intelligence tool designed to predict five-year breast cancer risk from a routine screening mammogram. fiercebiotech.com/medtech/fd…
Ayla Ellison retweeted
This week on "The Top Line," the Fierce team breaks down Big Pharma Q1 earnings, discusses gene therapy highlights from the @ASGCTherapy conference and shares an @ASCO meeting preview. omny.fm/shows/the-top-line/b…
Fierce 15 is here! Nominations are open now in search of the best and brightest in biotech. fiercebiotech.com/biotech/no…
Oracle Health, which has not publicly reported the incident, reportedly told customers its legacy Cerner systems were breached. fiercehealthcare.com/health-…
HHS is set to slash 10,000 full-time jobs and further remake the agency in the Trump administration’s vision. fiercehealthcare.com/regulat…
Penn Medicine cuts 300 roles fiercehealthcare.com/finance…
President Donald Trump’s Department of Government Efficiency (DOGE) has again revised savings estimates tied to federal site closures, nearly halving the unit’s initial forecast. fiercebiotech.com/biotech/do…
Ayla Ellison retweeted
Nominations are now open for Fierce Healthcare's Fierce 15 of 2025. For the seventh year in a row, we plan to highlight the "fiercest" private healthcare companies and startups bringing innovation to healthcare. Submit a nomination today!
bit.ly/3OZVOiF
Ayla Ellison retweeted
It sounds a bit like something out of science fiction, but a topical vaccine that is rubbed on the skin is now closer to reality than ever before. fiercebiotech.com/research/h…
United Healthcare CEO Brian Thompson was shot and killed outside of Midtown hotel in NYC this morning in a possibly targeted attack. fiercehealthcare.com/payers/…
Meet our 2024 Women of Influence. Each of the 10 women profiled this year is playing a major role in driving the industry forward. fiercehealthcare.com/special…
